Search research articles
Contact Us
Filters
Showing results (61-70 of 183) with videos related to
Page
of 19
Sort By:
Oncoimmunology
|
December 3, 2021
Tumor cell-derived IL-10 promotes cell-autonomous growth and immune escape in diffuse large B-cell lymphoma
Kristin Stirm, Peter Leary, Katrin Bertram, et al.
International Journal of Cancer
|
February 24, 2015
Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia
Constance Baer, Christopher C Oakes, Amy S Ruppert, et al.
Haematologica
|
March 11, 2021
Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy
Marc Zapatka, Eugen Tausch, Selcen Öztürk, et al.
Frontiers in Oncology
|
August 29, 2025
Implementing comprehensive geriatric assessment in an academic hematologic outpatient setting: experiences from medical doctors and patients
Steven Pierre Hiltgen, Heike A Bischoff-Ferrari, Michael Gagesch, et al.
British Journal of Haematology
|
January 3, 2013
Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib
George A Follows, Hannah Sims, David M Bloxham, et al.
Blood
|
May 27, 2006
Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemia
Thorsten Zenz, Matthias Ritgen, Peter Dreger, et al.
Annals of Hematology
|
July 25, 2025
Prophylactic Tocilizumab prior to infusion of CD19 CAR T-cells reduces therapy-related complications in older lymphoma patients
Sebastian M Stolz, Albulena Musa, Adrian Bachofner, et al.
Blood
|
August 1, 2009
Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial
Thorsten Zenz, Sonja Häbe, Tina Denzel, et al.
Haematologica
|
December 3, 2009
Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia
Dirk Kienle, Axel Benner, Carolin Läufle, et al.
Leukemia & Lymphoma
|
April 30, 2013
Next-generation sequencing of cancer consensus genes in lymphoma
Jennifer Hüllein, Alexander Jethwa, Tatjana Stolz, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 183) with videos related to
Sort By:
Page
of 19
Oncoimmunology
|
December 3, 2021
Tumor cell-derived IL-10 promotes cell-autonomous growth and immune escape in diffuse large B-cell lymphoma
Kristin Stirm, Peter Leary, Katrin Bertram, et al.
International Journal of Cancer
|
February 24, 2015
Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia
Constance Baer, Christopher C Oakes, Amy S Ruppert, et al.
Haematologica
|
March 11, 2021
Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy
Marc Zapatka, Eugen Tausch, Selcen Öztürk, et al.
Frontiers in Oncology
|
August 29, 2025
Implementing comprehensive geriatric assessment in an academic hematologic outpatient setting: experiences from medical doctors and patients
Steven Pierre Hiltgen, Heike A Bischoff-Ferrari, Michael Gagesch, et al.
British Journal of Haematology
|
January 3, 2013
Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib
George A Follows, Hannah Sims, David M Bloxham, et al.
Blood
|
May 27, 2006
Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemia
Thorsten Zenz, Matthias Ritgen, Peter Dreger, et al.
Annals of Hematology
|
July 25, 2025
Prophylactic Tocilizumab prior to infusion of CD19 CAR T-cells reduces therapy-related complications in older lymphoma patients
Sebastian M Stolz, Albulena Musa, Adrian Bachofner, et al.
Blood
|
August 1, 2009
Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial
Thorsten Zenz, Sonja Häbe, Tina Denzel, et al.
Haematologica
|
December 3, 2009
Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia
Dirk Kienle, Axel Benner, Carolin Läufle, et al.
Leukemia & Lymphoma
|
April 30, 2013
Next-generation sequencing of cancer consensus genes in lymphoma
Jennifer Hüllein, Alexander Jethwa, Tatjana Stolz, et al.
Page
of 19